Chris Degnan
Finanzdirektor/CFO bei GALERA THERAPEUTICS, INC.
Vermögen: 2 070 $ am 30.04.2024
Aktive Positionen von Chris Degnan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GALERA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Finanzdirektor/CFO | 21.10.2019 | - | |
Investor Relations Kontakt | 21.10.2019 | - | |
Unternehmenssekretär | 21.10.2019 | - |
Karriereverlauf von Chris Degnan
Ehemalige bekannte Positionen von Chris Degnan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01.03.2018 | 07.10.2019 |
Finanzdirektor/CFO | 01.03.2018 | 07.10.2019 | |
ENDO INTERNATIONAL PLC | Finanzdirektor/CFO | 01.11.2014 | 01.03.2018 |
ASTRAZENECA PLC | Finanzdirektor/CFO | 01.01.2004 | 01.11.2014 |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Finanzdirektor/CFO | - | - |
Ausbildung von Chris Degnan
University of Notre Dame | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Irland | 2 |
Vereinigtes Königreich | 2 |
Operativ
Director of Finance/CFO | 5 |
Comptroller/Controller/Auditor | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
VERRICA PHARMACEUTICALS INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
GALERA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
- Börse
- Insiders
- Chris Degnan
- Erfahrung